Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Interest Income Expense
Glenmark Life Sciences Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Interest Income Expense
-₹15.5m
|
CAGR 3-Years
74%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Interest Income Expense
-₹1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Interest Income Expense
-₹898.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Interest Income Expense
-₹1.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
25%
|
CAGR 10-Years
-15%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Interest Income Expense
₹2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Interest Income Expense
-₹3.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-23%
|
See Also
What is Glenmark Life Sciences Ltd's Interest Income Expense?
Interest Income Expense
-15.5m
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Interest Income Expense amounts to -15.5m INR.
What is Glenmark Life Sciences Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
25%
The average annual Interest Income Expense growth rates for Glenmark Life Sciences Ltd have been 74% over the past three years , 25% over the past five years .